During the third quarter, GDS Wealth Management trimmed its position in UnitedHealth Group by 10.7%, selling 5,297 shares and ending the period with 44,252 shares valued at $15.28 million. Cullen Frost Bankers cut its holdings by 27.1%, offloading 29,527 shares to finish the quarter with 79,459 shares worth $27.44 million. In contrast, several smaller investors entered or expanded positions: LFA Lugano Financial Advisors added approximately $25,000 in new holdings, Sagard Holdings committed $29,000, Grey Fox Wealth Advisors invested $33,000, and Islay Capital Management contributed $31,000. Riggs Asset Management boosted its stake by 69.4%, purchasing 43 additional shares for a total of 105 shares valued at $33,000. Overall, institutional investors control 87.9% of outstanding shares, underscoring concentrated ownership.

In the quarter ended October 28th, UnitedHealth Group reported revenue of $113.16 billion, marking a 12.2% year-over-year increase and closely aligning with consensus forecasts. Adjusted earnings per share reached $2.92, surpassing the projected $2.87 by $0.05. Profit margins remained stable, with a net margin of 4.04% and return on equity of 19.23%. These results reflected robust contribution from both core segments: UnitedHealthcare’s medical benefit ratios held at targeted levels and Optum services grew at double-digit rates, driven by increased utilization of technology-enabled care management.

Over the past several weeks, analysts have maintained overwhelmingly positive views. Jefferies raised its price objective from $317 to $409 and upheld a Buy recommendation. UBS lifted its target from $378 to $430, also with a Buy rating. Mizuho increased its goal to $430 and highlighted potential margin tailwinds from upcoming Medicare Advantage guidance. Goldman Sachs initiated coverage with a Buy stance and set a $406 objective. Piper Sandler trimmed its target slightly to $417 but retained an Overweight rating. Of the 29 published opinions, one is a Strong Buy, 17 are Buys, nine Hold, and two Sell, yielding a consensus of Moderate Buy.

UnitedHealth declared a quarterly dividend of $2.21 per share, payable December 16th to shareholders of record as of December 8th, representing an 8.4% increase over the prior year’s payout. This annualized distribution of $8.84 per share corresponds to a 46.1% payout ratio based on trailing earnings, balancing shareholder returns with ongoing investments in network expansion and technology platforms.